Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04524611 |
|---|---|
| Brief Title: | Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) (SEQUENCE) |
| First Submitted : | August 20, 2020 |
| First Submitted that Met QC Criteria : | August 20, 2020 |
| First Posted : | August 24, 2020 |
| Last Update Submitted that Met QC Criteria : | September 25, 2023 |
| Last Update Posted : | September 28, 2023 |